Inovio Pharmaceuticals closes $87.4 million underwritten financing
Inovio has closed its previously announced underwritten public offering of 10,925,000 shares of the Company's common stock, including 1,425,000 shares of common stock issued pursuant to the underwriter's option, at the public offering price of $8.00 per share. Gross proceeds were $87.4 million. May 05, 2015